Driving research of Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME / CFS),
Post Treatment Lyme Disease Syndrome (PTLDS), Fibromyalgia and Post COVID .

Dr. Ronald W. Davis is optimistic at the 2017 Invest in ME Research Conference

Dr. Ron Davis, Director of the OMF Scientific Advisory Board and Director of the Stanford Genome Technology Center, conveys his excitement about the latest progress being made in ME / CFS research, especially towards discovering treatments. Speaking from the recent Invest in ME (IiME) conference in London, UK, Dr. Davis discusses how ME / CFS research is growing, enthusiastic, and most importantly, focused on how we can make an impact on patients. Watch the video here.
Transcript available here.
To help fast-track ME / CFS research, please donate to OMF.

Stay Informed

Be the first to hear our research news.

Subscribe Now.

No thanks